Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Senthil Selvaraj

Showing results (71-80 of 117) with videos related to

Pageof 12
Sort By:
European Journal of Heart Failure|May 10, 2026
Outpatient clinic visits before and after hospitalizations for heart failure with and without transthyretin amyloid cardiomyopathyHubert B Haywood, Uchechukwu Ikeaba, Gregg C Fonarow, et al.
Journal of Nuclear Cardiology : Official Publication of the American Society of Nuclear Cardiology|October 21, 2020
Diagnostic accuracy of SPECT and PET myocardial perfusion imaging in patients with left bundle branch block or ventricular-paced rhythmMahesh K Vidula, Philip Wiener, Senthil Selvaraj, et al.
Journal of the American College of Cardiology|May 6, 2021
Atrial Fibrillation and Ischemic Stroke With the Amyloidogenic V122I Transthyretin Variant Among Black AmericansSenthil Selvaraj, Brian Claggett, Masatoshi Minamisawa, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|October 22, 2021
Comparison of Exogenous Ketone Administration Versus Dietary Carbohydrate Restriction on Myocardial Glucose Suppression: A Crossover Clinical TrialSenthil Selvaraj, Kenneth B Margulies, Supritha Dugyala, et al.
Journal of the American Heart Association|February 14, 2019
Axial Muscle Size as a Strong Predictor of Death in Subjects With and Without Heart FailureAnupam Kumar, Bilal A Ansari, Jessica Kim, et al.
Journal of the American Heart Association|May 17, 2021
Effects of Sacubitril/Valsartan on Serum Lipids in Heart Failure With Preserved Ejection FractionSenthil Selvaraj, Brian L Claggett, Milton Packer, et al.
Journal of Cardiac Failure|November 10, 2025
Clinical Outcomes and Health Care Costs in Patients Hospitalized With Heart Failure and Transthyretin Amyloid Cardiomyopathy: Findings From GWTG-HFSatoshi Shoji, Uchechukwu Ikeaba, Gregg C Fonarow, et al.
Circulation. Heart Failure|December 25, 2013
Prognostic importance of pathophysiologic markers in patients with heart failure and preserved ejection fractionMichael A Burke, Daniel H Katz, Lauren Beussink, et al.
European Journal of Heart Failure|November 18, 2017
Systolic blood pressure and cardiovascular outcomes in heart failure with preserved ejection fraction: an analysis of the TOPCAT trialSenthil Selvaraj, Brian Claggett, Sanjiv J Shah, et al.
JAMA Cardiology|May 22, 2023
Age Dependency of Cardiovascular Outcomes With the Amyloidogenic pV142I Transthyretin Variant Among Black Individuals in the USSenthil Selvaraj, Brian L Claggett, C Cristina Quarta, et al.
Pageof 12

Showing results (71-80 of 117) with videos related to

Sort By:
Pageof 12
European Journal of Heart Failure|May 10, 2026
Outpatient clinic visits before and after hospitalizations for heart failure with and without transthyretin amyloid cardiomyopathyHubert B Haywood, Uchechukwu Ikeaba, Gregg C Fonarow, et al.
Journal of Nuclear Cardiology : Official Publication of the American Society of Nuclear Cardiology|October 21, 2020
Diagnostic accuracy of SPECT and PET myocardial perfusion imaging in patients with left bundle branch block or ventricular-paced rhythmMahesh K Vidula, Philip Wiener, Senthil Selvaraj, et al.
Journal of the American College of Cardiology|May 6, 2021
Atrial Fibrillation and Ischemic Stroke With the Amyloidogenic V122I Transthyretin Variant Among Black AmericansSenthil Selvaraj, Brian Claggett, Masatoshi Minamisawa, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|October 22, 2021
Comparison of Exogenous Ketone Administration Versus Dietary Carbohydrate Restriction on Myocardial Glucose Suppression: A Crossover Clinical TrialSenthil Selvaraj, Kenneth B Margulies, Supritha Dugyala, et al.
Journal of the American Heart Association|February 14, 2019
Axial Muscle Size as a Strong Predictor of Death in Subjects With and Without Heart FailureAnupam Kumar, Bilal A Ansari, Jessica Kim, et al.
Journal of the American Heart Association|May 17, 2021
Effects of Sacubitril/Valsartan on Serum Lipids in Heart Failure With Preserved Ejection FractionSenthil Selvaraj, Brian L Claggett, Milton Packer, et al.
Journal of Cardiac Failure|November 10, 2025
Clinical Outcomes and Health Care Costs in Patients Hospitalized With Heart Failure and Transthyretin Amyloid Cardiomyopathy: Findings From GWTG-HFSatoshi Shoji, Uchechukwu Ikeaba, Gregg C Fonarow, et al.
Circulation. Heart Failure|December 25, 2013
Prognostic importance of pathophysiologic markers in patients with heart failure and preserved ejection fractionMichael A Burke, Daniel H Katz, Lauren Beussink, et al.
European Journal of Heart Failure|November 18, 2017
Systolic blood pressure and cardiovascular outcomes in heart failure with preserved ejection fraction: an analysis of the TOPCAT trialSenthil Selvaraj, Brian Claggett, Sanjiv J Shah, et al.
JAMA Cardiology|May 22, 2023
Age Dependency of Cardiovascular Outcomes With the Amyloidogenic pV142I Transthyretin Variant Among Black Individuals in the USSenthil Selvaraj, Brian L Claggett, C Cristina Quarta, et al.
Pageof 12